IG-DART Trademark

Trademark Overview

On Wednesday, September 21, 2011, a trademark application was filed for IG-DART with the United States Patent and Trademark Office. The USPTO has given the IG-DART trademark a serial number of 85428114. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 24, 2014. This trademark is owned by MacroGenics, Inc.. The IG-DART trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases
ig-dart

General Information

Serial Number85428114
Word MarkIG-DART
Filing DateWednesday, September 21, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 24, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 26, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMacroGenics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameMacroGenics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Monday, November 24, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 24, 2014ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 29, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 28, 2014EXTENSION 4 GRANTED
Wednesday, March 12, 2014EXTENSION 4 FILED
Wednesday, March 12, 2014TEAS EXTENSION RECEIVED
Wednesday, March 12, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 24, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 23, 2013EXTENSION 3 GRANTED
Tuesday, September 10, 2013EXTENSION 3 FILED
Tuesday, September 10, 2013TEAS EXTENSION RECEIVED
Tuesday, September 10, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2013EXTENSION 2 GRANTED
Friday, March 1, 2013EXTENSION 2 FILED
Friday, March 1, 2013TEAS EXTENSION RECEIVED
Wednesday, September 12, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 11, 2012EXTENSION 1 GRANTED
Thursday, September 6, 2012EXTENSION 1 FILED
Tuesday, September 11, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 6, 2012TEAS EXTENSION RECEIVED
Tuesday, April 24, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2012PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 12, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 9, 2012ASSIGNED TO EXAMINER
Monday, September 26, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 24, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

dart diseases disorders conditions inflammatory metabolic infectious cancer allergies autoimmune treatment